This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
Hybrid Event | 23 - 25 May 2023
Steigenberger Wiltcher's, Brussels

Hybrid Event | 23 - 25 May 2023
Steigenberger Wiltcher's, Brussels

Tuesday 23 May 2023

Competition Law & Patent Litigation: Theories of Harm, Case Reviews and Essential Updates

Interactive Discussions on Antitrust and IP Challenges with Competition Authorities and EU Commission

Dive In To Key Competition Law and Patient Litigation Perspectives On:

Commercial Implications Precautionary Advice From Recent Antitrust Activity:

  • Expanded Jurisdictional Reach In The Illumina/Grail Case
  • Product Denigration And Disparagement In The Vifor Pharma Case
  • Update On Judgement And Implications Of The Servier Case
  • EU Commission’s Statement Of Objections On The Teva Copaxone Case

Hear From Leading Competition Authorities On:

  • Active Enforcement And Progress Of Investigations In The Pharmaceutical Sector
  • The Netherland’s Investigations Into Excessive Pricing
  • Belgium Authority Scrutiny Into Biosimilars
  • French Authority Examinations Into Promotional Strategies And Disparagement

Insightful Patent Litigation Updates:

  • Unified Patent Court (UPC) And Implications On Litigation
  • Managing SPC Protection In territories Not Covered By a MA
  • Updates On Second Medical Use Patents
  • Review Of Decisions On Divisional Strategies For IP